Product Images Sumatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sumatriptan Succinate NDC 50090-5939 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical-structure - chemical structure
Label Image - lbl500905939
Sumatriptan-figure-1 - sumatriptan figure 1
This is a figure showing the estimated probability of achieving initial headache relief within 4 hours of treatment with oral sumatriptan. The data displayed is pooled from 3 clinical trials that have provided evidence of efficacy for the drug. The figure shows the probability of obtaining headache relief over time, with different dosages of the drug (25 mg, 50 mg, and 100 mg) and a placebo. The averages displayed are based on a Kaplan-Meier plot with patients not achieving response and/or taking rescue within 240 minutes censored to 240 minutes.*
Sumatriptan-figure-2 - sumatriptan figure 2
The text describes a figure (Figure 2) which illustrates the estimated probability of patients taking a second dose of Sumatriptan Succinate tablets, or other medication for treating migraine, within 24 hours of the initial dose. The figure uses data from Pooled Trials 1, 2, and 3, and shows the probability percentage against time in hours from initial dose on a Kaplan-Meier plot. The plot also takes into account patients who had no response to the initial dose and does not allow for remedication within 2 hours postdose.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.